Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PAOX | Q6QHF9 | 5/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.64 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.45 |
| ▸ | CES1 | P23141 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.44 |
| ▸ | PPARG | P37231 | 4/20 | 0.43 |
| ▸ | PPARD | Q03181 | 4/20 | 0.43 |
| ▸ | PPARA | Q07869 | 4/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.43 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.43 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.43 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.43 |
| ▸ | TLR2 | O60603 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12686704 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL14749721 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL11435600 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL16723870 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL3626142 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL11375880 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL2775487 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL8421741 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL21818217 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 | |
| SCHEMBL14725979 | 1.00 | PAOX (0.72) | PAOXALDH1A1ACHELMNASLC15A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11377411-B2 | Method for producing 3-methylcycloalkenone compound | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-07-05 | — | — | US | claimed |
| US-20220033336-A1 | METHOD FOR PRODUCING 3-METHYLCYCLOALKENONE COMPOUND | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2022-02-03 | — | — | US | claimed |
| CN-108191622-B | Continuous preparation method of DL-muscone | 广东省石油与精细化工研究院 | 2021-02-09 | — | — | CN | claimed |
| WO-2020067079-A1 | METHOD FOR PRODUCING 3-METHYLCYCLOALKENONE COMPOUND | 高砂香料工業株式会社 | 2020-04-02 | — | — | WO | claimed |
| EP-2412696-A1 | PROCESS FOR PRODUCTION OF 3-METHYL-CYCLOPENTADECENONE, PROCESS FOR PRODUCTION OF R/S-MUSCONE, AND PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE MUSCONE | Doya, Masaharu (JP) | 2012-02-01 | — | — | EP | claimed |
| US-20110172465-A1 | METHOD FOR PRODUCING 3-METHYL-CYCLOPENTADECENONES, METHOD FOR PRODUCING (R)- AND (S)- MUSCONE, AND METHOD FOR PRODUCING OPTICALLY ACTIVE MUSCONE | DOYA MASAHARU | 2011-07-14 | — | — | US | claimed |
| EP-1156029-B1 | Derivatives of acetoacetic acid, their process of preparation and their use | BASF AG (DE) | 2003-06-18 | — | — | EP | claimed |
| US-6515154-B2 | Acetoacetic acid derivatives, process for their preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 2003-02-04 | — | — | US | claimed |
| US-20010056195-A1 | Acetoacetic acid derivatives, process for their preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 2001-12-27 | — | — | US | claimed |
| EP-1156029-A1 | Derivatives of acetoacetic acid, their process of preparation and their use | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-21 | — | — | EP | claimed |
| EP-1102736-A2 | PREPARATION OF MACROCYCLIC KETONES UTILISING ADDITION OF KETONES TO ALKENES | QUEST INTERNATIONAL B.V. (NL) | 2001-05-30 | — | — | EP | claimed |
| EP-0976714-A1 | Addition of ketones to alkenes | QUEST INTERNATIONAL B.V. (NL) | 2000-02-02 | — | — | EP | claimed |
| WO-2000001648-A2 | PREPARATION OF MACROCYCLIC KETONES UTILISING ADDITION OF KETONES TO ALKENES | QUEST INTERNATIONAL B.V. (NL) | 2000-01-13 | — | — | WO | claimed |
| JP-59157047-A | — | — | None | — | — | JP | disclosed |
| JP-55085536-A | — | — | None | — | — | JP | disclosed |
| JP-59199650-A | — | — | None | — | — | JP | disclosed |
| EP-0400509-A1 | Process for the production of muscone, intermediates for this process and their preparation | BASF Aktiengesellschaft (DE) | 1990-12-05 | — | — | EP | disclosed |
| JP-S59199650-A | PRODUCTION OF LONG-CHAIN DIKETONE | NIPPON MINING CO LTD | 1984-11-12 | — | — | JP | disclosed |
| JP-S59157047-A | PREPARATION OF DEHYDROMUSCONE | NIPPON MINING CO LTD | 1984-09-06 | — | — | JP | disclosed |
| JP-S5585536-A | PREPARATION OF 3-METHYL-2-CYCLOPENTADECEN-1-ONE | NIPPON ZEON CO LTD | 1980-06-27 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010056195-A1 | Acetoacetic acid derivatives, process for their preparation and their use | ACMSD, MLYCD, HADHB | PAOX 277/4885ALDH1A1 20/4885ACHE 1565/4885 |
| US-11377411-B2 | Method for producing 3-methylcycloalkenone compound | MSMO1, CYP51A1, HSD17B7 | PAOX 2815/4885ALDH1A1 1554/4885ACHE 1102/4885 |
| US-20220033336-A1 | METHOD FOR PRODUCING 3-METHYLCYCLOALKENONE COMPOUND | MSMO1, CYP51A1, HSD17B7 | PAOX 2815/4885ALDH1A1 1554/4885ACHE 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.